The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia

Haematologica. 2008 Jul;93(7):1111-3. doi: 10.3324/haematol.12738. Epub 2008 May 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, High Pressure Liquid
  • Cohort Studies
  • Female
  • Genotype
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Male
  • Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic*
  • Proportional Hazards Models
  • Proto-Oncogene Proteins c-mdm2 / genetics*
  • Proto-Oncogene Proteins c-mdm2 / physiology
  • Sequence Analysis, DNA
  • Treatment Outcome

Substances

  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2